.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
US Department of Justice
Covington
Baxter
US Army
Deloitte
Accenture
Citi
QuintilesIMS

Generated: February 19, 2018

DrugPatentWatch Database Preview

Patents Expiring in 2032

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Spriaso LlcCODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATEchlorpheniramine maleate; codeine phosphateTABLET, EXTENDED RELEASE;ORAL206323-001Jun 22, 2015DISCNNoNo➤ Sign Up➤ Sign UpY
Spriaso LlcCODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATEchlorpheniramine maleate; codeine phosphateTABLET, EXTENDED RELEASE;ORAL206323-001Jun 22, 2015DISCNNoNo➤ Sign Up➤ Sign UpTREATMENT OF COUGH AND SYMPTOMS ASSOCIATED WITH UPPER RESPIRATORY ALLERGIES OR A COMMON COLD WITH CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE ORALLY ADMINISTERED EXTENDED RELEASE TABLETS
Indivior IncSUBLOCADEbuprenorphineSOLUTION, EXTENDED RELEASE;SUBCUTANEOUS209819-002Nov 29, 2017RXYesYes➤ Sign Up➤ Sign UpYTREATING OPIOID DEPENDENCE BY ADMINISTERING BUPRENORPHINE
Indivior IncSUBLOCADEbuprenorphineSOLUTION, EXTENDED RELEASE;SUBCUTANEOUS209819-002Nov 29, 2017RXYesYes➤ Sign Up➤ Sign UpYTREATING OPIOID DEPENDENCY BY ADMINISTERING BUPRENORPHINE ONCE PER MONTH
Indivior IncSUBLOCADEbuprenorphineSOLUTION, EXTENDED RELEASE;SUBCUTANEOUS209819-001Nov 29, 2017RXYesNo➤ Sign Up➤ Sign UpYTREATING OPIOID DEPENDENCE BY ADMINISTERING BUPRENORPHINE
Indivior IncSUBLOCADEbuprenorphineSOLUTION, EXTENDED RELEASE;SUBCUTANEOUS209819-001Nov 29, 2017RXYesNo➤ Sign Up➤ Sign UpYTREATING OPIOID DEPENDENCY BY ADMINISTERING BUPRENORPHINE ONCE PER MONTH
Teva PharmARMONAIR RESPICLICKfluticasone propionatePOWDER;INHALATION208798-003Jan 27, 2017RXYesYes➤ Sign Up➤ Sign UpY
Teva PharmARMONAIR RESPICLICKfluticasone propionatePOWDER;INHALATION208798-002Jan 27, 2017RXYesNo➤ Sign Up➤ Sign UpY
Teva PharmARMONAIR RESPICLICKfluticasone propionatePOWDER;INHALATION208798-001Jan 27, 2017RXYesNo➤ Sign Up➤ Sign UpY
OrexigenCONTRAVEbupropion hydrochloride; naltrexone hydrochlorideTABLET, EXTENDED RELEASE;ORAL200063-001Sep 10, 2014RXYesYes➤ Sign Up➤ Sign UpUSE OF NALTREXONE AND BUPROPION FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Fuji
Cerilliant
Queensland Health
Daiichi Sankyo
Cipla
McKesson
Express Scripts
Citi
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot